The 4 references in paper Jin-Ping Zheng, Fu-Qiang Wen, Chun-Xue Bai, Huan-Ying Wan, Jian Kang, Ping Chen, Wan-Zhen Yao, Li-jun Ma, Xia Li, Luca Raiteri, Marco Sardina, Yi Gao, Bai-Song Wang, Nan-Shan Zhong, Дж.-П. Женг, Ф.-К. Вен, Ч.-К. Бей, Х.-Я. Ван, Дж. Канг, П. Чен, В.-Ж. Яао, Л.-Дж. Ма, К. Ли, Д. Райтери, М. Сардина, И. Гао, Б.-С. Ванг, Н.-Ш. Зонг (2014) “РАНДОМИЗИРОВАННОЕ ДВОЙНОЕ СЛЕПОЕ ПЛАЦЕБО-КОНТРОЛИРУЕМОЕ ИССЛЕДОВАНИЕ PANTHEON: ПРИМЕНЕНИЕ N-АЦЕТИЛЦИСТЕИНА В ДОЗЕ 600 МГ 2 РАЗА В ДЕНЬ ПРИ ОБОСТРЕНИЯХ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ // TWICE DAILY N-ACETYLCYSTEINE 600 MG FOR EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (PANTHEON): A RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL” / spz:neicon:pulmonology:y:2014:i:3:p:86-98

1
Vestbo J., Hurd S.S., Agusti A.G. et al.Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2013; 187: 347–365.
(check this in PDF content)
2
Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57: 847–852.
(check this in PDF content)
3
Spencer S., Calverley P.M., Burge P.S., Jones P.W. Impact of preventing exacerbations on deterioration of health status in COPD. Eur. Respir. J. 2004; 23: 698–702. results from the confronting COPD survey. Respir. Med. 2003; 97 (Suppl. C): S51–59. 5.Blackwell T.S., Blackwell T.R., Holden E.P. et al.In vivo antioxidant treatment suppresses nuclear factor–kappa B activation and neutrophilic lung infl ammation. J. Immunol. 1996; 157: 1630–1637. 6.van Overveld F.J., Demkow U., Gorecka D. et al.New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine. J. Physiol. Pharmacol. 2005; 56 (Suppl. 4): 135–142. 7.Dekhuijzen P.N.R.Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic
(check this in PDF content)
4
Jin-Ping Zheng, Fu-Qiang Wen, Chun-Xue Bai et al.High-Dose N-Acetylcysteine in the Prevention of COPD Exacerbations: Rationale and Design of the PANTHEON Study. COPD. 2013; 10: 164–171. http://www.pulmonology.ru97 Таблица S6 Частота обострений разных типов по Anthonisen
(check this in PDF content)